Milky Mist Food Diary Shares Debut at 18% Premium
By United One News · AI-generated summary of 3 outlets' reporting
Published · Updated
AI-generated summary of the coverage listed below:
- Milky Mist Food Diary’s initial public offering, priced at Rs 140 per share, was oversubscribed 56.12 times and listed on the NSE and BSE on August 18.
- The shares opened at Rs 165, an 18% premium to the issue price, reflecting strong investor demand.
- The IPO raised Rs 1,553 crore, and analysts view the company’s long‑term prospects positively.
“Milky Mist shares made a strong stock market debut on August 18, listing at Rs 165 on NSE and BSE, an 18% premium over the Rs 140 IPO price.”
Covered by 7 outlets across the spectrum: 0% left, 14% center, 86% right.
How each side framed it
Milky Mist makes a stellar debut, ends 30% higher on Day 1
Milky Mist Food Diary Share Price: Stock Makes Strong Debut, Lists At 17.86% Premium At Rs 165
Left-leaning outlets have under-covered this story. Of 7 outlets, only 1 are on the left of the spectrum.
Timeline
First reported by Sunday Guardian on ; 7 articles from 3 outlets so far.
Who is covering this story
- Left-leaning (1): The New Indian Express
- Right-leaning (2): Sunday Guardian, Times Now
Sources
- Milky Mist Food Diary Share Price: Stock Makes Strong Debut, Lists At 17.86% Premium At Rs 165 — Sunday Guardian (right-leaning) ·
- Milky Mist IPO Listing: Shares Debut At 18% Premium Over Issue Price — Times Now (right-leaning) ·
- Behari Lal Engineering IPO Allotment Today: Did You Get BLEL Shares? Check Allotment Status On MUFG Intime, NSE And BSE — Sunday Guardian (right-leaning) ·
- Lalithaa Jewellery IPO Day 2: Issue Fully Subscribed at ₹1,700 Crore; What Should Investors Know Before Applying? Check GMP, Price Band, Risks & Other Key Details — Sunday Guardian (right-leaning) ·
- Milky Mist makes a stellar debut, ends 30% higher on Day 1 — The New Indian Express (left-leaning) ·
- Shiprocket Shares Make Strong Debut, List At 35% Premium On NSE: Here’s How Much Investors Made Per Lot — Sunday Guardian (right-leaning) ·
- Moderna Stock Price Today: Moderna Stock Rockets Higher After Positive Cancer Vaccine Trial – Here’s What Investors Should Know — Sunday Guardian (right-leaning) ·